Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Maravai Lifesciences Holdings Inc Cl A (MRVI)

Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

MRVI : 7.72 (-0.64%)
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript

MRVI earnings call for the period ending June 30, 2024.

MRVI : 7.72 (-0.64%)
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient...

APDN : 0.1810 (-2.00%)
MRVI : 7.72 (-0.64%)
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient...

APDN : 0.1810 (-2.00%)
MRVI : 7.72 (-0.64%)
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript

MRVI earnings call for the period ending March 31, 2024.

MRVI : 7.72 (-0.64%)
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript

MRVI earnings call for the period ending December 31, 2023.

MRVI : 7.72 (-0.64%)
Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript

MRVI earnings call for the period ending September 30, 2023.

MRVI : 7.72 (-0.64%)
Stock Index Futures Plunge as China Trade Data Disappoints, Moody's Downgrades U.S. Banks

September S&P 500 futures (ESU23) are down -0.45%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.49% this morning as fresh worries about China’s economic rebound and the state of U.S. banks...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
BRK.A : 663,564.00 (-0.18%)
SOVO : 22.98 (+0.13%)
TSN : 58.62 (+0.51%)
TSLA : 251.21 (+3.45%)
LLY : 801.51 (-0.57%)
UPS : 132.82 (-0.14%)
ZTS : 175.00 (-0.10%)
DUK : 112.94 (+0.37%)
GLEN.LN : 405.750 (-0.28%)
CHGG : 1.7100 (+2.40%)
Maravai LifeSciences (MRVI) Q2 2023 Earnings Call Transcript

MRVI earnings call for the period ending June 30, 2023.

MRVI : 7.72 (-0.64%)
Maravai LifeSciences (MRVI) Q1 2023 Earnings Call Transcript

MRVI earnings call for the period ending March 31, 2023.

MRVI : 7.72 (-0.64%)

Barchart Exclusives

Did This AI Chip Giant Just Score a Major Victory Over Nvidia?
With a new strategic partnership under its belt, can Broadcom steal AI chip king Nvidia’s crown? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar